, a bio/informatics shared resource is still "open for business" - Visit the CDS website


  1. Retraction Note: Transient cytokine treatment induces acinar cell reprogramming and regenerates functional beta cell mass in diabetic mice. Baeyens L, Lemper M, Leuckx G, De Groef S, Bonfanti P, Stangé G, Shemer R, Nord C, Scheel DW, Pan FC, Ahlgren U, Gu G, Stoffers DA, Dor Y, Ferrer J, Gradwohl G, Wright CVE, Van de Casteele M, German MS, Bouwens L, Heimberg H (2020) Nat Biotechnol 38(3): 374
    › Primary publication · 32066957 (PubMed) · PMC7175803 (PubMed Central)
  2. Myt Transcription Factors Prevent Stress-Response Gene Overactivation to Enable Postnatal Pancreatic β Cell Proliferation, Function, and Survival. Hu R, Walker E, Huang C, Xu Y, Weng C, Erickson GE, Coldren A, Yang X, Brissova M, Kaverina I, Appakalai BN, Wright CVE, Li Y, Stein R, Gu G (2020) Dev Cell 53(4): 390-405.e10
    › Primary publication · 32359405 (PubMed)
  3. Excitotoxicity and Overnutrition Additively Impair Metabolic Function and Identity of Pancreatic β-cells. Osipovich AB, Stancill JS, Cartailler JP, Dudek KD, Magnuson MA (2020) Diabetes
    › Primary publication · 32332159 (PubMed)
  4. Transgene-associated human growth hormone expression in pancreatic β-cells impairs identification of sex-based gene expression differences. Stancill JS, Osipovich AB, Cartailler JP, Magnuson MA (2019) Am J Physiol Endocrinol Metab 316(2): E196-E209
    › Primary publication · 30532991 (PubMed) · PMC6397359 (PubMed Central)
  5. Regulation of Glucose-Dependent Golgi-Derived Microtubules by cAMP/EPAC2 Promotes Secretory Vesicle Biogenesis in Pancreatic β Cells. Trogden KP, Zhu X, Lee JS, Wright CVE, Gu G, Kaverina I (2019) Curr Biol 29(14): 2339-2350.e5
    › Primary publication · 31303487 (PubMed) · PMC6698911 (PubMed Central)
  6. Prevention and Reversion of Pancreatic Tumorigenesis through a Differentiation-Based Mechanism. Krah NM, Narayanan SM, Yugawa DE, Straley JA, Wright CVE, MacDonald RJ, Murtaugh LC (2019) Dev Cell 50(6): 744-754.e4
    › Primary publication · 31422917 (PubMed) · PMC6776997 (PubMed Central)
  7. Point mutations in the PDX1 transactivation domain impair human β-cell development and function. Wang X, Sterr M, Ansarullah , Burtscher I, Böttcher A, Beckenbauer J, Siehler J, Meitinger T, Häring HU, Staiger H, Cernilogar FM, Schotta G, Irmler M, Beckers J, Wright CVE, Bakhti M, Lickert H (2019) Mol Metab : 80-97
    › Primary publication · 30930126 (PubMed) · PMC6531841 (PubMed Central)
  8. Myeloid Cell-Derived HB-EGF Drives Tissue Recovery After Pancreatitis. Wen HJ, Gao S, Wang Y, Ray M, Magnuson MA, Wright CVE, Di Magliano MP, Frankel TL, Crawford HC (2019) Cell Mol Gastroenterol Hepatol 8(2): 173-192
    › Primary publication · 31125624 (PubMed) · PMC6661420 (PubMed Central)
  9. Inactivation of mTORC2 in macrophages is a signature of colorectal cancer that promotes tumorigenesis. Katholnig K, Schütz B, Fritsch SD, Schörghofer D, Linke M, Sukhbaatar N, Matschinger JM, Unterleuthner D, Hirtl M, Lang M, Herac M, Spittler A, Bergthaler A, Schabbauer G, Bergmann M, Dolznig H, Hengstschläger M, Magnuson MA, Mikula M, Weichhart T (2019) JCI Insight 4(20)
    › Primary publication · 31619583 (PubMed) · PMC6824305 (PubMed Central)
  10. Imaging mass spectrometry enables molecular profiling of mouse and human pancreatic tissue. Prentice BM, Hart NJ, Phillips N, Haliyur R, Judd A, Armandala R, Spraggins JM, Lowe CL, Boyd KL, Stein RW, Wright CV, Norris JL, Powers AC, Brissova M, Caprioli RM (2019) Diabetologia 62(6): 1036-1047
    › Primary publication · 30955045 (PubMed) · PMC6553460 (PubMed Central)